These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


242 related items for PubMed ID: 6934710

  • 1. Hypocholesterolemia in myeloproliferative disorders.
    Spanos GA, Bajaj K, Rosner F.
    Arch Intern Med; 1981 Jan; 141(1):137-8. PubMed ID: 6934710
    [No Abstract] [Full Text] [Related]

  • 2. Myelofibrosis in the myeloproliferative disorders.
    Ellis JT, Peterson P.
    Prog Clin Biol Res; 1984 Jan; 154():19-42. PubMed ID: 6382293
    [Abstract] [Full Text] [Related]

  • 3. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R, Marzetta K, Miglioranza A, Redaelli S, Maino C, Maffiolini A, Gorini M.
    Recenti Prog Med; 2003 Jan; 94(7-8):314-20. PubMed ID: 12868237
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
    Tangün Y.
    Thromb Diath Haemorrh; 1971 Jun 30; 25(2):241-51. PubMed ID: 5284903
    [No Abstract] [Full Text] [Related]

  • 6. [Characteristics of the morphology and function of the thrombocytes in myeloproliferative diseases].
    Petrov MN, Vashkinel' VK.
    Probl Gematol Pereliv Krovi; 1977 May 30; 22(5):18-23. PubMed ID: 267283
    [No Abstract] [Full Text] [Related]

  • 7. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
    Greenberg PL.
    Clin Haematol; 1986 Nov 30; 15(4):973-93. PubMed ID: 3552351
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Vascular changes in bone marrow in blood diseases].
    Demmler K, Burkhardt R.
    Med Klin; 1980 Apr 25; 75(9):328-32. PubMed ID: 7402170
    [No Abstract] [Full Text] [Related]

  • 10. [Hypocholesterolemia and other lipoprotein disorders in myelofibrosis].
    Kiss A, Telek B, Rák K.
    Orv Hetil; 1994 Nov 27; 135(48):2643-6. PubMed ID: 7808738
    [Abstract] [Full Text] [Related]

  • 11. Plasma fibronectin in idiopathic myelofibrosis and related chronic myeloproliferative disorders.
    Hasselbalch H, Clemmensen I.
    Scand J Clin Lab Invest; 1987 Sep 27; 47(5):429-33. PubMed ID: 3477850
    [Abstract] [Full Text] [Related]

  • 12. [Polycythemia and splenomegaly in a 51-year-old woman].
    Ribera JM, Abella E, Lloreta J.
    Med Clin (Barc); 1995 Jul 01; 105(5):191-6. PubMed ID: 7630233
    [No Abstract] [Full Text] [Related]

  • 13. Bone marrow biopsy in clinical medicine: an overview.
    Frisch B, Bartl R, Burkhardt R.
    Haematologia (Budap); 1982 Jul 01; 15(3):245-85. PubMed ID: 6764442
    [Abstract] [Full Text] [Related]

  • 14. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP, Sanchez SR, Ewton AA, Rice L, Perkins SL, Dunphy CH, Chang CC.
    Hum Pathol; 2008 Oct 01; 39(10):1454-8. PubMed ID: 18619646
    [Abstract] [Full Text] [Related]

  • 15. Classification of myeloproliferative disorders by bone marrow histology.
    Frisch B, Bartl R, Burkhardt R, Jäger K, Mahl G, Kettner G.
    Bibl Haematol; 1984 Oct 01; (50):57-80. PubMed ID: 6590039
    [No Abstract] [Full Text] [Related]

  • 16. [Fibrous changes in the bone marrow in myelocytic leukemia].
    Shalaev VA, Streneva TN.
    Probl Gematol Pereliv Krovi; 1979 Dec 01; 24(12):30-4. PubMed ID: 293653
    [No Abstract] [Full Text] [Related]

  • 17. Polycythemia vera and myelofibrosis: correlation of MR imaging, clinical, and laboratory findings.
    Kaplan KR, Mitchell DG, Steiner RM, Murphy S, Vinitski S, Rao VM, Burk DL, Rifkin MD.
    Radiology; 1992 May 01; 183(2):329-34. PubMed ID: 1561331
    [Abstract] [Full Text] [Related]

  • 18. Platelet function and arachidonate metabolism in patients with myeloproliferative disorders.
    Okuma M.
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec 01; 43(6):1139-44. PubMed ID: 6800179
    [No Abstract] [Full Text] [Related]

  • 19. Platelet survival, platelet factor-4 and bleeding time in myeloproliferative disorders.
    Berild D, Hasselbalch H, Knudsen JB.
    Scand J Clin Lab Invest; 1987 Sep 01; 47(5):497-501. PubMed ID: 3477851
    [Abstract] [Full Text] [Related]

  • 20. Studies on the phagocytic activity of neutrophilic leukocytes.
    Brandt L.
    Scand J Haematol Suppl; 1967 Sep 01; 2():1-126. PubMed ID: 5243720
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.